Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe dos and don'ts on Mounjaro come down to a handful of genuinely important habits — and a longer list of myths people follow unnecessarily. Mounjaro (tirzepatide) is a once-weekly prescription injection that works by activating two gut-hormone receptors to reduce appetite and slow digestion; getting the most from it means knowing which rules are evidence-based and which are just internet noise. As a prescription-only medicine, it's prescribed only after a clinician has assessed your health picture, so the specific guidance that applies to you always comes from your prescriber and the Patient Information Leaflet included with your pen. What follows covers the practical facts that apply across the board.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception that trips people up most consistently. Mounjaro suppresses appetite significantly (many people find they feel full after smaller portions within the first few weeks) but the medicine is licensed alongside a reduced-calorie diet and increased physical activity, not instead of them. The SURMOUNT-1 trial, which underpins NICE's recommendation of tirzepatide, was conducted with structured lifestyle support throughout. Participants who leaned into the behavioural side got more from the medicine, not less.
In practice, this means: do prioritise protein at each meal. When appetite is low, it's easy to eat too little protein and lose muscle alongside fat. Aim for vegetables, lean meat, fish, eggs, legumes. Do drink enough water, dehydration compounds nausea and constipation, two of the most common early side effects. Don't skip meals entirely; very small, regular portions tend to suit people on tirzepatide better than long fasts, which can make nausea worse.
Strength exercise matters here too. It won't override a poor diet, but it does help preserve muscle mass during weight loss. You don't need a gym, resistance bands, bodyweight work, carrying shopping. The point is consistency, not intensity. If you've been wondering why progress has stalled despite the injection, the lifestyle component is usually the first place to look, and our full breakdown of do's and don'ts on Mounjaro is a good place to work through the detail. Our Mounjaro overview covers the full licensed context if you want more background.
There's a right way to handle a Mounjaro KwikPen and a few common mistakes that reduce how reliably the medicine is delivered. Do keep the pen refrigerated between 2°C and 8°C, the fridge door is fine. The exact room-temperature window you have if you're travelling or your fridge fails is in the SmPC; always check the Patient Information Leaflet on the eMC rather than relying on a figure someone quoted online, because the window is specific and the consequences of an out-of-condition pen matter.
Do inject on a consistent day each week. You can shift the day by a day or two if needed (say, to avoid an important event) but never inject two doses within 72 hours of each other. Rotate your injection site every week: abdomen, outer thigh, upper arm. Using the same patch of skin repeatedly builds up a small lump of changed tissue that can slow absorption unpredictably.
Don't try to adjust your own dose. The titration schedule exists to reduce nausea and other gastrointestinal effects as your body adjusts. Moving up faster than your prescriber has planned (or staying on a lower dose longer to save money without clinical input) both carry real downsides. If you want to understand the full schedule, our guide to Mounjaro dosing explains how the titration works and why each step exists.
Finally: don't share pens, don't reuse needles, and dispose of used pens in a proper sharps container. That last point sounds obvious, but it's one of the things people ask our prescribers about more often than you'd expect.
Feeling rough in the first few weeks is common and doesn't mean something has gone wrong, but knowing which symptoms to ride out and which to act on is important. Nausea, loose stools, constipation, burping and mild fatigue are the most frequent early complaints. They tend to peak in the 24–48 hours after an injection and ease over days to weeks. Eating smaller portions, avoiding fatty or very spicy food, and staying hydrated all help. If nausea is disrupting your life, speak to your prescriber about the pace of titration before deciding to stop.
The NHS tirzepatide medicines page sets out the full list of known side effects clearly. The ones that warrant prompt medical attention are different in character: severe stomach pain that spreads to your back (a warning sign for pancreatitis), signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing), or symptoms of gallbladder problems such as sharp pain under the right rib. These are infrequent, but they're the reason this medicine is prescription-only and not something to take without clinical oversight.
If you're not feeling any different after several weeks, that's a separate question worth raising with your prescriber, it doesn't always mean the medicine isn't working. Our page on not feeling different on Mounjaro unpacks the most common reasons. For a wider read on how tirzepatide compares and what to expect, the tirzepatide information page is a useful next step.
A few things that matter and tend to slip through the cracks. Don't take oral contraceptive pills as your only form of contraception during the first four weeks of Mounjaro treatment or for four weeks after each dose increase. Slowed gastric emptying can reduce how well the pill is absorbed; NHS guidance recommends adding a barrier method (such as condoms) during those windows. If you use HRT, discuss with your doctor whether a transdermal form (patch or gel) suits you better while on tirzepatide, for the same reason.
Don't keep this treatment secret from other healthcare providers. If you're having surgery (even minor day-case procedures) your anaesthetist needs to know you're on a GLP-1 medicine. The slowed gastric emptying changes how fasting before surgery is managed. Tell your GP too; it affects how your broader health picture is read.
Do report any side effects you're concerned about. The MHRA's Yellow Card scheme lets patients report suspected adverse effects directly, and it contributes to the ongoing safety monitoring that all medicines under Black Triangle status receive. If you have questions about cost or what's included in a private prescription, the context around Mounjaro pricing is worth reading before you compare providers. If you're ready to find out whether you're suitable, our prescribers are the right next step, not a checklist.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.